The antioxidant effects of statins may extend beyond atherosclerosis: Potential benefits for atrial fibrillation and heart failure [2]

Atherosclerosis

Volumn 175, Issue 1, 2004, Pages 187-

  Korantzopoulos, Panagiotis ^a   Kokkoris, Stelianos ^b  

^a G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; RECURRENT DISEASE;

ANTIOXIDANTS; ARTERIOSCLEROSIS; ATRIAL FIBRILLATION; HEART FAILURE, CONGESTIVE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 2942523135     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.03.016     Document Type: Letter

References (10)

1. Rosenson R.S. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis. 173:2004;1-12
2. Norata G.D., Pirillo A., Catapano A.L. Statins and oxidative stress during atherogenesis. J. Cardiovasc. Risk. 10:2003;181-189
3. Franzoni F., Quinones-Galvan A., Regoli F., Ferrannini E., Galetta F. A comparative study of the in vitro antioxidant activity of statins. Int. J. Cardiol. 90:2003;317-321
4. Carnes C.A., Chung M.K., Nakayama T., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 89:2001;e32-e38
5. Korantzopoulos P., Galaris D., Papaioannides D., Kokkoris S. C-reactive protein and oxidative stress in atrial fibrillation. Int. J. Cardiol. 88:2003;103-104
6. Korantzopoulos P., Kolettis T., Siogas K., Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med. Sci. Monit. 9:2003;RA225-RA229
7. Siu C.W., Lau C.P., Tse H.F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am. J. Cardiol. 92:2003;1343-1345
8. Young-Xu Y., Jabbour S., Goldberg R., et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary heart disease. Am. J. Cardiol. 92:2003;1379-1383
9. Korantzopoulos P., Galaris D., Papaioannides D., Siogas K. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med. Sci. Monit. 9:2003;RA120-RA125
10. Horwich T.B., MacLellan R., Fonarow G.C. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J. Am. Coll. Cardiol. 43:2004;642-648